Feasibility and acceptability of a self-measurement using a portable bioelectrical impedance analysis, by the patient with chronic heart failure, in acute decompensated heart failure

The Possibility of Using Bioelectrical Impedance Analysis in Pregnant and Postpartum Women

“…BIA measurements can also be used in non-invasive assessments in case of chronic vestibular disorders [42]. This method was also widely used in patients with heart disease [43], including heart failure [44][45][46]. The physical properties of BIA, its measurement variables and their clinical significance, have been well described in many previously published reports [5,47].…”

Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure

“…We, therefore, evaluated the effects of combined therapy with tolvaptan plus furosemide versus furosemide monotherapy on both intracellular water volume (ICW) and extracellular water volume (ECW), measured using a multi-frequency bioelectrical impedance analyzer (BIA) and on the size of the inferior vena cava (IVC) and its respiratory variation using echocardiography as an assessment of intravascular volume status. BIA has been widely applied to assess the fluid status in patients with HF, renal failure, and hepatic cirrhosis [12][13][14][15][16]. With BIA measurement, it is possible to measure ICW and ECW separately [17,18].…”